1. Osborn wave in a patient with COVID-19: a case report
- Author
-
K. M. Talipova, Damir Gareev, Timur Ilgamovich Musin, Valentin Pavlov, N. Sh. Zagidullin, P. A. Davtyan, Zilya Adibovna Bagmanova, Anton Viktorovich Tyurin, and Ruslan Mansurovich Gumerov
- Subjects
covid-19 pneumonia ,medicine.medical_specialty ,Myocardial ischemia ,Coronavirus disease 2019 (COVID-19) ,030204 cardiovascular system & hematology ,osborn wave ,03 medical and health sciences ,Pericarditis ,0302 clinical medicine ,Electrolyte imbalance ,Internal medicine ,medicine ,Diseases of the circulatory (Cardiovascular) system ,030212 general & internal medicine ,Pathological ,Human body temperature ,Lung ,business.industry ,Hypothermia ,medicine.disease ,medicine.anatomical_structure ,covid-19 ,RC666-701 ,Cardiology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
The classic Osborn wave in the form of characteristic changes at the depolarization end or ventricular repolarization beginning is more often associated with hypothermia (body temperature below 35,60 C). Some researchers have noticed Osborn wave at normal body temperature, various pathological conditions and diseases: hypercalcemia, myocardial ischemia, postoperative pericarditis, with central nervous system, etc. We presented a case report of a 72-year-old female inpatient with moderate COVID-19, confirmed by polymerase chain reaction, and 48% lung damage. Before admission to the hospital, electrocardiogram had no Osborn wave, which first appeared at admission. There was a significant increase in serum C-reactive protein and a moderate increase in serum biomarkers and no changes in intervals and segments on the electrocardiogram. The appearance of Osborn wave may be associated with intramyocardial electrolyte imbalance, a consequence of antiviral and antibacterial therapy that violate intraventricular conduction. © 2021, Silicea-Poligraf. All rights reserved.
- Published
- 2021